IMC opposes a January 15, 2021 proposal to redefine ‘gap’ medicines and change the timeline for compliance – which halves the transition period to six months.
PMPRB Guidelines Notice and Comment
resources
Discover. Learn.
Understand.
Stay informed with timely, relevant content on key issues shaping our industry.
